Anna Vaqué

Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial

Jordi Bruna, Sebastián Videla, Andreas A. Argyriou et al. · Neurotherapeutics · 2017 · 117 citations · Full text

Pain Medicine, Cancer Management, Oxaliplatin-induced Peripheral Neuropathy +21

Safety, tolerability and pharmacokinetics of single and multiple doses of a novel sigma‐1 receptor antagonist in three randomized phase I studies

Montserrat Abadías, Marisol Escriche, Anna Vaqué et al. · British Journal of Clinical Pharmacology · 2012 · 67 citations · Full text

Pup circadian rhythm entrainment—effect of maternal ganglionectomy or pinealectomy

S.L. Bellavı́a, Ágata R. Carpentieri, Anna Vaqué et al. · Physiology & Behavior · 2006 · 51 citations

Animal Physiology, Maternal Ganglionectomy, Neurophysiology +10

Single‐dose pharmacokinetics of co‐crystal of tramadol–celecoxib: Results of a four‐way randomized open‐label phase I clinical trial in healthy subjects

Sebastián Videla, Mounia Lahjou, Anna Vaqué et al. · British Journal of Clinical Pharmacology · 2017 · 45 citations · Full text

Celecoxib-tramadol co-crystal: A Randomized 4-Way Crossover Comparative Bioavailability Study

Jesús Cebrecos, James D. Carlson, Gregorio Encina et al. · Clinical Therapeutics · 2021 · 34 citations · Full text